The past few decades have not produced a new, successful pharmacological prevention, treatment, or cure of Alzheimer’s disease. Addressing amyloid and tau protein buildup has only resulted in failed clinical trials.
The inability to identify the cause, or more likely causes of this disease, is the underlying issue.
In this article from NewScientist, the author makes a compelling case to further pursue the hypothesis that the bacterium involved in gum disease may be responsible for Alzheimer’s in some people.
Tom Tressler is the director of customer development for HiLois. He has a rich background in healthcare and technology. He covers health, technology and healthy aging news for the HiLois blog.